Current Vascular Pharmacology
Title:Meet Our Regional Editor
Volume: 16 Issue: 4
Author(s): Greg J. Dusting
Affiliation:
Export Options
About this article
Cite this article as:
Dusting J. Greg , Meet Our Regional Editor, Current Vascular Pharmacology 2018; 16 (4) . https://dx.doi.org/10.2174/157016111604180517091313
DOI https://dx.doi.org/10.2174/157016111604180517091313 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The GH/IGF-1 Axis and Heart Failure
Current Cardiology Reviews The Concept of “Neuroprotection” in Neurological Diseases
Current Neuropharmacology Erythropoietin in Cancer: An Update
Current Molecular Medicine Recent Synthetic Strategies for Monocyclic Azole Nucleus and Its Role in Drug Discovery and Development
Current Organic Synthesis Gene Therapy for Neuroprotection and Neurorestoration (Part I)
Current Gene Therapy Editorial: Recent Advances in Cardiovascular and Circulatory Signalling
Current Vascular Pharmacology Role of Wnt Signaling in Tissue Fibrosis, Lessons from Skeletal Muscle and Kidney
Current Molecular Medicine Contribution of Catecholamine Reactive Intermediates and Oxidative Stress to the Pathologic Features of Heart Diseases
Current Medicinal Chemistry Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Immunogenicity and Tumorigenicity of Pluripotent Stem Cells and their Derivatives: Genetic and Epigenetic Perspectives
Current Stem Cell Research & Therapy Gestational Diabetes Mellitus Pharmacological Prevention and Treatment
Current Pharmaceutical Design Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Peripartum Cardiomyopathy: Current State of Knowledge, New Developments and Future Directions
Current Cardiology Reviews Modulators of the Vascular Endothelin Receptor in Blood Pressure Regulation and Hypertension
Current Molecular Pharmacology GLUT4 Associated Proteins as Therapeutic Targets for Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Norepinephrine and Autonomic Modulation in Heart Failure
Current Cardiology Reviews Drug Metabolism and Pharmacokinetics of Dammarane Triterpenoids
Current Drug Metabolism Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
Current Pharmaceutical Design The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance
Current Pharmaceutical Design